Researchers have called for an urgent review of recommended blood pressure levels for people with diabetes, after finding even patients within current ‘safe’ levels benefited from having their blood pressure lowered.
The team’s analysis included 40 randomised clinical trials, and found a 27% reduction in the risk of stroke and 11% reduced risk of coronary heart disease events among patients who achieved a 10mmHg reduction in systolic levels.
Overall mortality was also 13% lower with a 10mmHg reduction, relative to higher systolic pressures, while retinopathy and albuminuria risks were reduced by 13% and 17%, respectively.
The researchers said this showed treatment goals for blood pressure in current guidelines are too slack.
European guidelines were recently revised – bringing them nore closely in line with NICE guidelines – to relax maximum blood pressure levels for high-risk patients, such as those with diabetes, to the 140/90mmHg threshold recommended for other patients with hypertension.
NICE recommends patients with type 2 diabetes have blood pressure levels kept below 140/90 mmHg, or 130/80 mmHg if they have kidney, eye or cerebrovascular disease.
Study author Professor Kazem Rahimi, a cardiologist and deputy director of the George Institute at the University of Oxford, said: ‘Our review shows that people with diabetes who reached a systolic blood pressure below 130mmHg had about a 25% lower stroke risk compared with those with higher blood pressure levels.’
He added: ‘Unfortunately, recent US and EU changes to the guidelines will negatively impact the treatment options for people with diabetes in the UK. We urgently call for these recent changes to guidelines to be modified and for all guidelines around the world to consistently reflect the evidence.’
Hypertension expert Professor Neil Poulter, from Imperial College London, who was not involved in the study, backed the researchers’ call for a change in guidelines.
Professor Poulter said: ‘I expect this study to influence guidelines for the treatment of people with diabetes, and for this to translate to appreciable effects on the health of people with diabetes.
‘I have been increasingly concerned about the trend to advocate higher blood pressure targets as reflected by recent changes to guidelines in Europe and the US; this study provides the evidence needed to reconsider this.’
But Professor Bryan Williams, professor of at University College London, said GPs should not wait for guidelines to change but consider taking a ‘bolder’ approach to tackling high blood pressure in younger patients in particular.
Writing in a related editorial, Professor Williams said: ‘It would seem reasonable to consider a bolder approach to blood pressure treatment in younger patients with diabetes and especially those with albuminuria or other early manifestations of microvascular or macrovascular disease than currently advocated in guidelines.’
Want to win a Samsung Smart HD TV? Then take Pulse’s multi-topic survey covering a range of areas, from recruitment to NICE guidelines, and the GP contract.
It should take just a couple of minutes to complete, and will help Pulse gain a vital insight into the views of the profession.